$0.08 EPS Expected for Care.com Inc (NYSE:CRCM) This Quarter

Wall Street analysts expect Care.com Inc (NYSE:CRCM) to report earnings of $0.08 per share for the current quarter, Zacks reports. Three analysts have issued estimates for Care.com’s earnings. Care.com posted earnings of $0.14 per share in the same quarter last year, which would suggest a negative year over year growth rate of 42.9%. The firm is expected to announce its next quarterly earnings report before the market opens on Tuesday, August 6th.

On average, analysts expect that Care.com will report full-year earnings of $0.56 per share for the current year, with EPS estimates ranging from $0.54 to $0.59. For the next fiscal year, analysts forecast that the company will report earnings of $0.68 per share, with EPS estimates ranging from $0.67 to $0.69. Zacks’ EPS calculations are an average based on a survey of analysts that that provide coverage for Care.com.

Care.com (NYSE:CRCM) last released its earnings results on Thursday, May 9th. The information services provider reported $0.12 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.05) by $0.17. The company had revenue of $53.30 million for the quarter, compared to analysts’ expectations of $52.75 million. Care.com had a return on equity of 7.81% and a net margin of 24.80%. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.19 EPS.

CRCM has been the topic of a number of recent analyst reports. ValuEngine upgraded Zogenix from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 27th. Craig Hallum upgraded Western Digital from a “hold” rating to a “buy” rating and lifted their target price for the stock from $49.00 to $54.00 in a research note on Wednesday, June 26th. Stifel Nicolaus upgraded Kimbell Royalty Partners from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a research note on Thursday, May 9th. Zacks Investment Research upgraded DLH from a “sell” rating to a “hold” rating in a research note on Tuesday, July 9th. Finally, Roth Capital set a $33.00 target price on Stemline Therapeutics and gave the stock a “buy” rating in a research note on Friday, May 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $17.17.

Shares of NYSE CRCM traded up $0.10 during mid-day trading on Friday, reaching $10.73. 22,229 shares of the company’s stock were exchanged, compared to its average volume of 711,152. The firm has a market cap of $347.50 million, a price-to-earnings ratio of 29.75 and a beta of 1.00. Care.com has a 52 week low of $10.62 and a 52 week high of $25.81. The company has a quick ratio of 2.75, a current ratio of 2.75 and a debt-to-equity ratio of 0.14. The stock has a 50-day moving average price of $12.83.

In related news, General Counsel Diane Musi sold 1,738 shares of Care.com stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $16.35, for a total value of $28,416.30. Following the completion of the sale, the general counsel now owns 33,865 shares of the company’s stock, valued at approximately $553,692.75. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Sheila Lirio Marcelo sold 9,805 shares of Care.com stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $14.37, for a total value of $140,897.85. Following the completion of the sale, the chief executive officer now directly owns 1,221,974 shares of the company’s stock, valued at approximately $17,559,766.38. The disclosure for this sale can be found here. In the last three months, insiders sold 32,509 shares of company stock valued at $489,953. 28.10% of the stock is currently owned by insiders.

A number of hedge funds have recently bought and sold shares of CRCM. BNP Paribas Arbitrage SA grew its holdings in Care.com by 82,800.0% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,145 shares of the information services provider’s stock valued at $82,000 after buying an additional 4,140 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in Care.com by 192.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,732 shares of the information services provider’s stock valued at $94,000 after buying an additional 3,116 shares in the last quarter. Great West Life Assurance Co. Can purchased a new position in Care.com during the 4th quarter valued at about $96,000. Metropolitan Life Insurance Co. NY grew its holdings in Care.com by 263.6% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 5,337 shares of the information services provider’s stock valued at $103,000 after buying an additional 3,869 shares in the last quarter. Finally, LS Investment Advisors LLC purchased a new position in Care.com during the 1st quarter valued at about $125,000. 86.53% of the stock is owned by institutional investors and hedge funds.

About Care.com

Care.com, Inc operates an online marketplace for finding and managing family care in the United States and internationally. The company helps families to address their lifecycle of care needs, including child care, senior care, and special needs care, as well as other non-medical family care needs, such as pet care, tutoring, and housekeeping; and enables caregivers to find full-time and part-time employment opportunities.

Recommended Story: Why do companies engage in swaps?

Get a free copy of the Zacks research report on Care.com (CRCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with MarketBeat.com's FREE daily email newsletter.